Atrial Fibrillation (AF) Clinical Trial
— CHAZESubstrateOfficial title:
Characterization of Left Atrial Substrate by Comparison of Bipolar Voltage Maps With Standard Focal 4.5 mm Tip Electrode, 1 mm Ring Electrode, and Microelectrode Catheters Using InTEllaMap Orion and IntellaNav MIFI O
Verified date | November 2021 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study is to investigate the correlation and to obtain the coefficient of correlation between the global and local bipolar signals (voltage maps) of the LA in sinus rhythm using a focal 4.5 mm irrigated-tip ablation catheter (in combination with microelectrodes), a ring-electrode circular mapping catheter and a microelectrode multipolar catheter in combination with the Rhythmia system.
Status | Completed |
Enrollment | 25 |
Est. completion date | May 31, 2021 |
Est. primary completion date | May 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Documented atrial fibrillation - First or repeat catheter ablation Exclusion Criteria: - Previous heart surgery (high probability for atypical atrial tachycardia and non PV triggers for AF) - Congenital heart disease (corrected or uncorrected) - Severe uncorrected valvular heart disease - Not willing or qualified for Magnetic Resonance Imaging of the heart - Unable to provide informed consent - Pregnancy (Pregnancy test will be performed before study participation) - Patients with pacemaker or intracardiac defibrillator implanted |
Country | Name | City | State |
---|---|---|---|
Switzerland | Cardiology/Electrophysiology, University Hospital Basel | Basel |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland | Boston Scientific Corporation |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Global bipolar and unipolar signal measured in millivolt (mV) | Global bipolar and unipolar signal for the different types of catheters measured in mV | single time point assessment at baseline | |
Primary | Local bipolar and unipolar signal measured in mV | Local bipolar and unipolar signal for the different types of catheters measured in mV | single time point assessment at baseline | |
Secondary | Global fibrosis content and distribution from LGE-MRI measured in [%]. | Global fibrosis content and distribution from LGE-MRI measured in [%]. | single time point assessment at baseline | |
Secondary | Local fibrosis content and distribution from Late-gadolinium enhanced Magnetic Resonance Imaging (LGE-MRI) measured in [%]. | Local fibrosis content and distribution from LGE-MRI measured in [%]. | single time point assessment at baseline | |
Secondary | Differences of bipolar voltage characteristics between nearfield and farfield signals: amplitude (mV) | Differences of bipolar voltage characteristics between nearfield and farfield signals: amplitude (mV) | single time point assessment at baseline | |
Secondary | Differences of bipolar voltage characteristics between nearfield and farfield signals: frequency in Hertz (Hz) | Differences of bipolar voltage characteristics between nearfield and farfield signals: frequency (Hz) | single time point assessment at baseline | |
Secondary | Differences of bipolar voltage characteristics between nearfield and farfield signals: Duration in milliseconds (ms) | Differences of bipolar voltage characteristics between nearfield and farfield signals: duration (ms) | single time point assessment at baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02630914 -
Medical and Surgical Hybrid Treatment of Atrial Fibrillation.
|
N/A | |
Completed |
NCT05410379 -
Antral Lesions Characterization of a New Cryoballoon Ablation System in Terms of Local Impedance Drop
|
||
Enrolling by invitation |
NCT05407415 -
KardiaMobile ECG Monitoring Effects on Health Care Utilization and Patient Experience With Atrial Fibrillation
|
N/A | |
Completed |
NCT04025710 -
Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep)
|
N/A | |
Completed |
NCT01119274 -
EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon
|
Phase 4 | |
Recruiting |
NCT03428048 -
Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.
|
||
Recruiting |
NCT04298723 -
Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
|
N/A | |
Completed |
NCT04218266 -
Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.
|
Phase 2 | |
Active, not recruiting |
NCT03732794 -
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
|
N/A | |
Active, not recruiting |
NCT04755283 -
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
|
Phase 2 | |
Recruiting |
NCT05712200 -
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
|
Phase 3 | |
Recruiting |
NCT05955365 -
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
|
Phase 4 | |
Recruiting |
NCT05294445 -
From the Emergency Department Directly to Ablation of Atrial Fibrillation Study
|
N/A | |
Completed |
NCT02513316 -
Clinical Relevance of Microbleeds In Stroke
|
N/A | |
Completed |
NCT04809922 -
Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation
|